Home Real Estate Life Sciences – A Burgeoning Real Estate Asset Class | White &...

Life Sciences – A Burgeoning Real Estate Asset Class | White & Case LLP

0

In the last few years, and very much following in the footsteps of the US, the UK’s life sciences sector has grown exponentially. This growth has been accelerated by Governmental support for the scientific community in the wake of Brexit, as well as the increased spotlight on life sciences and pharma following the COVID-19 pandemic. From a real estate perspective, recent research from Jones Lang LaSalle has estimated that there is up to £15bn of capital which has been allocated by funds and various other real estate investors for the sector, of which only approximately 10% has been deployed to date. Investors are attracted from both the UK and internationally into the UK’s “Golden Triangle” of London, Oxford and Cambridge. But what are the key requirements for the legal documentation that are specific to this asset class?

Start-up and Early-Stage – v Mid-Stage and Scale Up

In order to answer this question, we first need to consider that there…

Click here for full article…